Reported 450,065 shares, up 444,212 (7589.5%) from the prior quarter.
Reported value 7117.0%; share count 7589.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 8965000 |
| 2022-06-30 | 7386000 |
| 2022-09-30 | 5843000 |
| 2022-12-31 | 14499429 |
| 2023-03-31 | 13392464 |
| 2023-06-30 | 18336569 |
| 2023-09-30 | 68585 |
| 2023-12-31 | 65729 |
| 2024-03-31 | 4743685 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -450,065 (-100.0%) | 0 | $0 | 2024-08-13 | |
| Q1 2024 | Added | 450,065 | +444,212 (7589.5%) | 0.02% | $4,743,685 | 2024-05-13 | |
| Q4 2023 | Reduced | 5,853 | -19 (-0.3%) | < 0.01% | $65,729 | 2024-02-13 | |
| Q3 2023 | Reduced | 5,872 | -1,813,232 (-99.7%) | < 0.01% | $68,585 | 2023-11-13 | |
| Q2 2023 | Added | 1,819,104 | +4,407 (0.2%) | 0.11% | $18,336,569 | 2023-08-04 | |
| Q1 2023 | Unchanged | 1,814,697 | 0 (0.0%) | 0.09% | $13,392,464 | 2023-05-12 | |
| Q4 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.1% | $14,499,429 | 2023-02-10 | |
| Q3 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.04% | $5,843,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.05% | $7,386,000 | 2022-08-12 | |
| Q1 2022 | New | 1,814,697 | +1,814,697 (0.0%) | 0.05% | $8,965,000 | 2022-05-13 |
Who else reported the position
296 managers reported ROIVANT SCIENCES LTD for Q1 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS UK LTD | Unchanged | 73,031,667 | 0 | 7.6% | $769,753,770 | 10 qtrs |
| VIKING GLOBAL INVESTORS LP | Unchanged | 69,368,961 | 0 | 2.72% | $731,148,849 | 10 qtrs |
| QVT Financial LP | Reduced | 66,719,779 | -45,821,757 | 59.48% | $703,226,471 | 10 qtrs |
| Atalaya Capital Management LP | Unchanged | 37,476 | 0 | 0.46% | $394,997,000 | 3 qtrs |
| BlackRock Inc | Added | 36,187,519 | +15,381,918 | < 0.01% | $381,416,451 | 10 qtrs |
| MORGAN STANLEY | Added | 35,635,501 | +13,708,457 | 0.03% | $375,598,194 | 10 qtrs |
| FMR LLC | Reduced | 35,340,563 | -1,635,685 | 0.03% | $372,489,534 | 10 qtrs |
| Rubric Capital Management LP | Added | 20,000,000 | +1,000,000 | 6.23% | $210,800,000 | 6 qtrs |
| STATE STREET CORPORATION | Added | 17,153,134 | +3,425,716 | < 0.01% | $180,794,032 | 10 qtrs |
| Patient Square Capital LP | Reduced | 12,228,465 | -411,455 | 54.89% | $128,888,021 | 6 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2024
- Filed
- May 13, 2024
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
- Sole
- 450,065
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.